Xanthoma tendinosum
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
15
|
22
|
0.100 |
None |
|
0 |
|
|
|
Xanthoma
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
29
|
4
|
0.120 |
None |
1.000 |
2 |
|
1982 |
1988 |
Vitamin Deficiency
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
17
|
2
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Virus Diseases
|
group |
Infections
|
Disease or Syndrome
|
1471
|
42
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2017 |
Ventricular Dysfunction, Left
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
88
|
|
0.100 |
None |
|
0 |
|
|
|
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.040 |
None |
1.000 |
4 |
|
2004 |
2009 |
Triple vessel disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
13
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
1998 |
1998 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
10 |
9
|
2007 |
2019 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thrombophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
161
|
43
|
0.010 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Thrombocytosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
93
|
12
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Thin-cap fibroatheroma
|
phenotype |
Cardiovascular Diseases
|
Acquired Abnormality
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Testosterone deficiency
|
disease |
|
Disease or Syndrome
|
24
|
1
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Tauopathies
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
245
|
43
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Tangier Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
31
|
28
|
0.020 |
None |
1.000 |
2 |
|
1990 |
2001 |
Supravalvular aortic stenosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
23
|
38
|
0.100 |
None |
|
0 |
|
|
|
Sudden Cardiac Death
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
133
|
40
|
0.100 |
None |
|
0 |
|
|
|
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.500 |
None |
1.000 |
19 |
|
1996 |
2018 |
Steatocystoma multiplex
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
3
|
4
|
0.010 |
None |
1.000 |
1 |
|
1991 |
1991 |
Staphylococcus aureus infection
|
disease |
Infections
|
Disease or Syndrome
|
49
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2013 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2013 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2013 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2013 |